FDA import refusal: Lidocaine (Belgium)
FDA refuses entry of lidocaine from Belgium—check your suppliers!
What changed & why it matters
Med Spa Radar recorded an FDA import refusal at the federal level, dated July 21, 2026, in the Aesthetic Injectables category, naming LIDOCAINE.
An import refusal marks a shipment of LIDOCAINE the FDA stopped at the U.S. border as violative — the gray-market corridor a med spa must never source injectables from. Foreign, unapproved, or misbranded product refused at import is exactly what surfaces when a practice buys outside verified US-licensed 503A/503B or FDA-registered channels.
- Type
- FDA Import Refusal
- Jurisdiction
- Federal
- Category
- Aesthetic Injectables
- Substance
- LIDOCAINE
- Recorded
- July 21, 2026
What this means for your specific practice — the exact step to take, the deadline to calendar, or the supplier detail to check — is in the member "what to do" below. This page is the free record of what changed and why it matters.
Firm inspection: Official Action Indicated
This firm’s most recent FDA inspection was classified Official Action Indicated (OAI) — FDA’s most serious outcome, signaling significant violations.
Source: FDA Data Dashboard inspection classifications (most recent, by firm FEI).
What to do
Free weekly Brief
Get the changes that matter in plain English, every week — and be alerted when the rules move. No charge.
Members get the full “what to do” on every alert — in real time, for your states. Become a member →
The FDA record
- Firm
- Laboratoria Qualiphar NV
- Origin
- Bornem, Belgium
- Product
- Lidocaine
- FDA classification
- Human Drugs
- Refused
- Jul 21, 2026
- FDA district
- Division of Northern Border Imports
- Firm FEI
- 1000627334
- FDA shipment ID
- 231-7818618-2/10002/1
Why FDA refused it
Adulteration501(a)(2)(B), 801(a)(3); ADULTERATION
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the methods used in and controls used for the manufacture, processing, packing, or holding of drugs and other products do not appear to conform to current good manufacturing practices within the meaning of Section 501(a)(2)(B).
FDA charge codes on this record: 27 (Adulteration). Definitions via the FDA Refusal Charges Reference.
Verify at FDA
FDA doesn’t publish a page per refusal. Open the FDA Import Refusals database and search by shipment ID 231-7818618-2/10002/1 (or firm FEI 1000627334), refused Jul 21, 2026.
FDA Import Refusal · FDA Import Refusals database ↗FDA record · Laboratoria Qualiphar NV · Bornem · drug product · refused as adulteration
Related alerts
- FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (South Korea)
- FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Brazil)
- FDA import refusal: Botox (onabotulinumtoxinA) (Ireland)
- FDA import refusal: Implant, Dermal, Collagen for Aesthetic Use (Vietnam)
- FDA import refusal: Botox (onabotulinumtoxinA) (Vietnam)
- FDA import refusal: Acid, Hyaluronic, Intraarticular (Sweden)
Monitoring, not legal advice.